Literature DB >> 18164557

Primary pure large-cell neuroendocrine carcinoma of the ovary.

Pavel Dundr1, Daniela Fischerová, Ctibor Povýsil, David Cibula.   

Abstract

We report a case of a 73-year-old female with a rare simultaneous occurrence of three tumors: ovarian carcinoma, endometrial carcinoma, and breast carcinoma. The ovarian tumor was a primary pure large-cell neuroendocrine carcinoma. Grossly, the left ovary was enlarged by a solid tumor that measured 9 x 7 x 7 cm. Histologically, the tumor consisted of large cells with irregular hyperchromatic nuclei and a moderate amount of eosinophilic cytoplasm. In some areas, the tumor cells were arranged in solid sheets; however, the predominant pattern was cribriform and solid-alveolar, with palisaded tumor cells located peripherally. The tumor cells showed multiple mitotic figures (up to 43 mitoses/10 HPF). Large areas of tumor necrosis were found. Immunohistochemically, the tumor cells were positive for EMA, synaptophysin, chromogranin, CD56, and CEA. Cytokeratin 20 was positive focally. Primary large-cell neuroendocrine carcinoma of the ovary is a rare tumor. To the best of our knowledge, only 4 cases of a pure tumor of this type have been reported to date.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18164557     DOI: 10.1016/j.prp.2007.09.004

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  12 in total

1.  Clinical features of ovarian large-cell neuroendocrine carcinoma: Four case reports and review of the literature.

Authors:  Takafumi Oshita; Tomomi Yamazaki; Yumiko Akimoto; Hirotoshi Tanimoto; Nobutaka Nagai; Masaru Mitao; Akio Sakatani; Mayumi Kaneko
Journal:  Exp Ther Med       Date:  2011-08-03       Impact factor: 2.447

2.  Large Cell Neuroendocrine Carcinoma of the Ovary and Its Skin Metastases: A Case Report and Review of the Literature.

Authors:  S Cokmert; L Demir; L Doganay; N Demir; K Kocacelebi; I T Unek; E Gezer; K Kilic; M Alakavuklar
Journal:  West Indian Med J       Date:  2014-07-03       Impact factor: 0.171

3.  Large cell neuroendocrine carcinoma of the ovary associated with serous carcinoma with mucin production: a case report and literature review.

Authors:  Rossitza Anguelova Draganova-Tacheva; Jasvirs S Khurana; Yajue Huang; Enrique Hernandez; Xinmin Zhang
Journal:  Int J Clin Exp Pathol       Date:  2008-11-08

4.  Large cell neuroendocrine carcinoma of the ovary: A pathologic entity in search of clinical identity.

Authors:  Ioannis A Voutsadakis
Journal:  World J Clin Oncol       Date:  2014-05-10

5.  CK20 Positive Large-cell Neuroendocrine Carcinoma Presenting with Skin Metastases.

Authors:  Min-Kyung Shin; Chang-Min Choi; Yu-Jin Oh; Nack-In Kim
Journal:  Ann Dermatol       Date:  2011-09-30       Impact factor: 1.444

Review 6.  Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature.

Authors:  Eun Young Ki; Jong Sup Park; Keun Ho Lee; Seog Nyeon Bae; Soo Young Hur
Journal:  World J Surg Oncol       Date:  2014-10-15       Impact factor: 2.754

7.  Role of diagnostic laparoscopy in patients with large cell neuroendocrine carcinoma of the ovary with cancerous peritonitis: case report and review of the literature.

Authors:  Hideaki Tsuyoshi; Kenji Yashiro; Shizuka Yamada; Makoto Yamamoto; Toshimichi Onuma; Tetsuji Kurokawa; Yoshio Yoshida
Journal:  J Ovarian Res       Date:  2019-10-15       Impact factor: 4.234

8.  Pure large cell neuroendocrine carcinoma of ovary: a rare clinical entity and review of literature.

Authors:  P N Shakuntala; K Uma Devi; K Shobha; U D Bafna; M Geetashree
Journal:  Case Rep Oncol Med       Date:  2012-12-06

9.  Neuroendocrine Tumors of the Female Reproductive Tract: A Literature Review.

Authors:  Yi Kyeong Chun
Journal:  J Pathol Transl Med       Date:  2015-10-13

Review 10.  Gynecologic large cell neuroendocrine carcinoma: A review.

Authors:  Grant Burkeen; Aman Chauhan; Rohitashva Agrawal; Riva Raiker; Jill Kolesar; Lowell Anthony; B Mark Evers; Susanne Arnold
Journal:  Rare Tumors       Date:  2020-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.